Ceo & Founder
CurrentBioCrowd is building a decentralized science (DeSci) marketplace where top global scientists can find funding faster, collaboration and leverage an easier distribution of life changing ownership/royalties for biotech and healthcare innovations along the life of the IP. We are building a virtual accelerator platform to provide capital and resources to accelerate innovation in high impact and underserved areas of medical research with a collaborative drug discovery platform with AI tools.Intro Video, 2:28https://youtu.be/-OiK9MOVxLs BioCrowd is introducing a platform for 1. A liquid marketplace for on-chain intellectual property (IP) 2. The ability for digital asset holders to earn a % of profits from IP licensing, buy, sell, marketplace using SEC compliant private securities. BioCrowd screens, nurtures, and advances translational research projects or early-stage companies for licensing or acquisition by “Big Pharma” or other strategics as another feeder channel more cost effectively, with a global talent pool and a faster go to market. We are building a Web3 marketplace for investing in IP rights and future cash flow royalties as an issuer and an investment vehicle.Investors will be able to find earlier stage vetted opportunities that do not exist today, and patient advocacy groups and communities can direct research and receive tokens for their participation. The US crypto market has been challenging but we believe we have a regulated solution to help investors, researchers and community yet address regulatory obstacles.https://www.biocrowd.io/